686 related articles for article (PubMed ID: 15942574)
41. The development of tissue-engineered grafts for reconstructive cardiothoracic surgical applications.
Mirensky TL; Breuer CK
Pediatr Res; 2008 May; 63(5):559-68. PubMed ID: 18427302
[TBL] [Abstract][Full Text] [Related]
42. Bone marrow genesis after subcutaneous delivery of rat osteogenic cell-seeded biodegradable scaffolds into nude mice.
Gomi K; Kanazashi M; Lickorish D; Arai T; Davies JE
J Biomed Mater Res A; 2004 Dec; 71(4):602-7. PubMed ID: 15499636
[TBL] [Abstract][Full Text] [Related]
43. Tissue engineering of viable pulmonary arteries for surgical correction of congenital heart defects.
Leyh RG; Wilhelmi M; Rebe P; Ciboutari S; Haverich A; Mertsching H
Ann Thorac Surg; 2006 Apr; 81(4):1466-70; discussion 1470-1. PubMed ID: 16564294
[TBL] [Abstract][Full Text] [Related]
44. Experimental study on reconstruction of segmental mandible defects using tissue engineered bone combined bone marrow stromal cells with three-dimensional tricalcium phosphate.
He Y; Zhang ZY; Zhu HG; Qiu W; Jiang X; Guo W
J Craniofac Surg; 2007 Jul; 18(4):800-5. PubMed ID: 17667668
[TBL] [Abstract][Full Text] [Related]
45. In vivo autologous recellularization of a tissue-engineered heart valve: are bone marrow mesenchymal stem cells the best candidates?
Vincentelli A; Wautot F; Juthier F; Fouquet O; Corseaux D; Marechaux S; Le Tourneau T; Fabre O; Susen S; Van Belle E; Mouquet F; Decoene C; Prat A; Jude B
J Thorac Cardiovasc Surg; 2007 Aug; 134(2):424-32. PubMed ID: 17662783
[TBL] [Abstract][Full Text] [Related]
46. Living patches engineered from human umbilical cord derived fibroblasts and endothelial progenitor cells.
Schmidt D; Mol A; Neuenschwander S; Breymann C; Gössi M; Zund G; Turina M; Hoerstrup SP
Eur J Cardiothorac Surg; 2005 May; 27(5):795-800. PubMed ID: 15848316
[TBL] [Abstract][Full Text] [Related]
47. Growth of bone marrow stromal cells on small intestinal submucosa: an alternative cell source for tissue engineered bladder.
Zhang Y; Lin HK; Frimberger D; Epstein RB; Kropp BP
BJU Int; 2005 Nov; 96(7):1120-5. PubMed ID: 16225540
[TBL] [Abstract][Full Text] [Related]
48. Valved bovine jugular vein conduits for right ventricular outflow tract reconstruction in children: an attractive alternative to pulmonary homograft.
Brown JW; Ruzmetov M; Rodefeld MD; Vijay P; Darragh RK
Ann Thorac Surg; 2006 Sep; 82(3):909-16. PubMed ID: 16928507
[TBL] [Abstract][Full Text] [Related]
49. Improved tissue-engineered bone regeneration by endothelial cell mediated vascularization.
Yu H; VandeVord PJ; Mao L; Matthew HW; Wooley PH; Yang SY
Biomaterials; 2009 Feb; 30(4):508-17. PubMed ID: 18973938
[TBL] [Abstract][Full Text] [Related]
50. Bone marrow mesenchymal stem cells form ectopic woven bone in vivo through endochondral bone formation.
Chang SC; Tai CL; Chung HY; Lin TM; Jeng LB
Artif Organs; 2009 Apr; 33(4):301-8. PubMed ID: 19335406
[TBL] [Abstract][Full Text] [Related]
51. Mechanical stretch regimen enhances the formation of bioengineered autologous cardiac muscle grafts.
Akhyari P; Fedak PW; Weisel RD; Lee TY; Verma S; Mickle DA; Li RK
Circulation; 2002 Sep; 106(12 Suppl 1):I137-42. PubMed ID: 12354723
[TBL] [Abstract][Full Text] [Related]
52. Novel tissue-engineered biodegradable material for reconstruction of vascular wall.
Iwai S; Sawa Y; Taketani S; Torikai K; Hirakawa K; Matsuda H
Ann Thorac Surg; 2005 Nov; 80(5):1821-7. PubMed ID: 16242461
[TBL] [Abstract][Full Text] [Related]
53. Repair of canine mandibular bone defects with bone marrow stromal cells and porous beta-tricalcium phosphate.
Yuan J; Cui L; Zhang WJ; Liu W; Cao Y
Biomaterials; 2007 Feb; 28(6):1005-13. PubMed ID: 17092556
[TBL] [Abstract][Full Text] [Related]
54. Myocardial Assistance by Grafting a New Bioartificial Upgraded Myocardium (MAGNUM trial): clinical feasibility study.
Chachques JC; Trainini JC; Lago N; Cortes-Morichetti M; Schussler O; Carpentier A
Ann Thorac Surg; 2008 Mar; 85(3):901-8. PubMed ID: 18291168
[TBL] [Abstract][Full Text] [Related]
55. Scaffold seeded with cells is essential in urothelium regeneration and tissue remodeling in vivo after bladder augmentation using in vitro engineered graft.
Drewa T; Sir J; Czajkowski R; Wozniak A
Transplant Proc; 2006; 38(1):133-5. PubMed ID: 16504684
[TBL] [Abstract][Full Text] [Related]
56. A novel small-diameter vascular graft: in vivo behavior of biodegradable three-layered tubular scaffolds.
Zhang L; Zhou J; Lu Q; Wei Y; Hu S
Biotechnol Bioeng; 2008 Mar; 99(4):1007-15. PubMed ID: 17705246
[TBL] [Abstract][Full Text] [Related]
57. Evaluation of partially demineralized osteoporotic cancellous bone matrix combined with human bone marrow stromal cells for tissue engineering: an in vitro and in vivo study.
Liu G; Sun J; Li Y; Zhou H; Cui L; Liu W; Cao Y
Calcif Tissue Int; 2008 Sep; 83(3):176-85. PubMed ID: 18704250
[TBL] [Abstract][Full Text] [Related]
58. Combined marrow stromal cell-sheet techniques and high-strength biodegradable composite scaffolds for engineered functional bone grafts.
Zhou Y; Chen F; Ho ST; Woodruff MA; Lim TM; Hutmacher DW
Biomaterials; 2007 Feb; 28(5):814-24. PubMed ID: 17045643
[TBL] [Abstract][Full Text] [Related]
59. Heart valve tissue engineering.
Neuenschwander S; Hoerstrup SP
Transpl Immunol; 2004 Apr; 12(3-4):359-65. PubMed ID: 15157927
[TBL] [Abstract][Full Text] [Related]
60. Tissue engineering approach to the treatment of bone tumors: three cases of cultured bone grafts derived from patients' mesenchymal stem cells.
Morishita T; Honoki K; Ohgushi H; Kotobuki N; Matsushima A; Takakura Y
Artif Organs; 2006 Feb; 30(2):115-8. PubMed ID: 16433845
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
